Literature DB >> 22236199

Tissue-specific differences in inflammatory infiltrate and matrix metalloproteinase expression in adipose tissue and liver of mice with diet-induced obesity.

Vincent E de Meijer1, Deanna Y Sverdlov, Hau D Le, Yury Popov, Mark Puder.   

Abstract

AIM: While low grade inflammation persists in both visceral fat and hepatic tissue in obesity, these changes often result in progressive disease and fibrosis only in the liver and not in adipose tissue. We hypothesized that a tissue-specific difference in obesity-induced inflammatory cell infiltrate may be responsible for such organ difference in susceptibility to fibrosis.
METHODS: Mice were fed either standard chow or a high fat diet over 19 weeks. Hepatic steatosis was assessed by histology and quantified via magnetic resonance spectroscopy. Immunohistochemistry staining for macrophage subsets and quantitative reverse transcription-polymerase chain reaction for matrix metalloproteinase (MMP)- and fibrosis-related gene expression was performed in paired livers and visceral (epididymal) fat pads at early (9 weeks) and advanced (19 weeks) stages of progressive diet-induced obesity.
RESULTS: Up to 19 weeks of high fat feeding led to the development of obesity and hepatic steatosis, as well as increased gene expression of Mmp12, Mmp13 and Timp1 in predominantly adipose tissue, and to a lesser extent of liver tissue. In contrast to visceral fat, cell counts for macrophages as well as profibrogenic gene signaling in liver tissue during development of diet-induced obesity remained largely unchanged.
CONCLUSIONS: Development of diet-induced obesity in the mouse increased inflammatory macrophages counts in adipose tissue rather than the liver. This was associated with greater increases in MMP expression in adipose tissue compared with liver. We propose that attenuated hepatic MMP expression in livers and adipose tissue of obese mice shifts the balance of fibrogenesis/fibrolysis and predispose the liver to development of fibrosis.
© 2012 The Japan Society of Hepatology.

Entities:  

Year:  2012        PMID: 22236199     DOI: 10.1111/j.1872-034X.2011.00960.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  14 in total

Review 1.  Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesis.

Authors:  Jun Wei Lim; John Dillon; Michael Miller
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Surgical removal of the parametrial fat pads stimulates apoptosis and inhibits UVB-induced carcinogenesis in mice fed a high-fat diet.

Authors:  Yao-Ping Lu; You-Rong Lou; Jamie J Bernard; Qing-Yun Peng; Tao Li; Yong Lin; Weichung Joe Shih; Paul Nghiem; Sue Shapses; George C Wagner; Allan H Conney
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

Review 3.  Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases.

Authors:  Aina He; Guo-Ping Shi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

4.  Serum SPARC and matrix metalloproteinase-2 and metalloproteinase-9 concentrations after bariatric surgery in obese adults.

Authors:  Yeon Ji Lee; Yoon-Seok Heo; Hye Soon Park; Seoung Hee Lee; Seul Ki Lee; Yeon Jin Jang
Journal:  Obes Surg       Date:  2014-04       Impact factor: 4.129

5.  Adipose tissue-derived free fatty acids initiate myeloid cell accumulation in mouse liver in states of lipid oversupply.

Authors:  Daniel B Harmon; Chao Wu; Nikolaos Dedousis; Ian J Sipula; Maja Stefanovic-Racic; Gabriele Schoiswohl; Christopher P O'Donnell; Laura C Alonso; Erin E Kershaw; Eric E Kelley; Robert M O'Doherty
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-08-07       Impact factor: 4.310

6.  Human cardiovascular disease IBC chip-wide association with weight loss and weight regain in the look AHEAD trial.

Authors:  Jeanne M McCaffery; George D Papandonatos; Gordon S Huggins; Inga Peter; Bahar Erar; Steven E Kahn; William C Knowler; Edward W Lipkin; Abbas E Kitabchi; Lynne E Wagenknecht; Rena R Wing
Journal:  Hum Hered       Date:  2013-09-27       Impact factor: 0.444

7.  Identification of matrix metalloproteinase-12 as a candidate molecule for prevention and treatment of cardiometabolic disease.

Authors:  M Amor; V Moreno Viedma; A Sarabi; N G Grün; B Itariu; L Leitner; I Steiner; M Bilban; K Kodama; A J Butte; G Staffler; M Zeyda; T M Stulnig
Journal:  Mol Med       Date:  2016-06-30       Impact factor: 6.354

8.  Host and tumor derived MMP13 regulate extravasation and establishment of colorectal metastases in the liver.

Authors:  Alisha M Mendonsa; Michael N VanSaun; Alessandro Ustione; David W Piston; Barbara M Fingleton; David Lee Gorden
Journal:  Mol Cancer       Date:  2015-02-22       Impact factor: 27.401

9.  Role of MMP-1 (-519A/G, -1607 1G/2G), MMP-3 (Lys45Glu), MMP-7 (-181A/G), and MMP-12 (-82A/G) Variants and Plasma MMP Levels on Obesity-Related Phenotypes and Microvascular Reactivity in a Tunisian Population.

Authors:  Soumaya Boumiza; Sarra Bchir; Hela Ben Nasr; Ammar Abbassi; Marie-Paule Jacob; Xavier Norel; Zouhair Tabka; Karim Chahed
Journal:  Dis Markers       Date:  2017-11-26       Impact factor: 3.434

Review 10.  The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Detlef Schuppan; Henning Grønbæk; Konstantin Kazankov; Simon Mark Dahl Jørgensen; Karen Louise Thomsen; Holger Jon Møller; Hendrik Vilstrup; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-03       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.